Published in Circulation on May 17, 2012
Management of Kawasaki disease. Arch Dis Child (2013) 2.30
Epidemiologic features and prognostic factors of coronary artery lesions associated with Kawasaki disease based on a 13-year cohort of consecutive cases identified by complete enumeration surveys in Wakayama, Japan. J Epidemiol (2014) 0.89
Building a Natural Language Processing Tool to Identify Patients With High Clinical Suspicion for Kawasaki Disease from Emergency Department Notes. Acad Emerg Med (2016) 0.89
Cardiovascular pathology in 2 young adults with sudden, unexpected death due to coronary aneurysms from Kawasaki disease in childhood. Cardiovasc Pathol (2015) 0.78
Coronary Artery Complications in Pediatric Patients with Kawasaki Disease: A 12-Year National Survey. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2013) 0.78
High Sensitivity C Reactive Protein (hs-CRP) in Adolescent and Young Adult Patients with History of Kawasaki Disease. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2015) 0.77
Tissue Doppler Imaging as a Predictor of Immunoglobulin Resistance in Kawasaki Disease. Pediatr Cardiol (2015) 0.77
Acute myocardial ischemia in adults secondary to missed Kawasaki disease in childhood. Am J Cardiol (2014) 0.77
Evaluating a novel treatment for coronary artery inflammation in acute Kawasaki disease: A Phase I/IIa trial of atorvastatin. Expert Opin Orphan Drugs (2015) 0.76
A 19 year old with Fever, rash, and conjunctivitis: a connection with the heart. Open Forum Infect Dis (2015) 0.75
Acute myocardial infarction in a 35-year-old man with coronary artery aneurysm most probably caused by Kawasaki disease. Asian Pac J Trop Biomed (2014) 0.75
Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility. PLoS One (2017) 0.75
Pediatric Coronary Artery Revascularization Surgery: Development and Effects on Survival, Cardiac Events and Graft Patency for Children With Kawasaki Disease Coronary Involvements. Iran J Pediatr (2016) 0.75
Coronary artery disease: Consider Kawasaki disease when assessing myocardial ischemia. Nat Rev Cardiol (2012) 0.75
Association between ascending aortic diameter and coronary artery dilation: a demographic data analysis. J Int Med Res (2016) 0.75
Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med (2005) 28.21
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
[Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi (1967) 9.06
Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation (1996) 7.29
A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med (1991) 5.76
Mucocutaneous lymph node syndrome in the United States. Am J Dis Child (1976) 2.52
Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr (2008) 2.44
Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics (2003) 2.36
Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol (1996) 2.18
Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey. J Epidemiol (2010) 2.09
Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J (1994) 1.99
Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet (1992) 1.97
Increasing incidence of Kawasaki disease in Japan: nationwide survey. Pediatr Int (2008) 1.90
When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood. J Am Coll Cardiol (2009) 1.88
Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience. Circulation (2011) 1.58
Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation (2000) 1.54
Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol Jpn (1991) 1.51
Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2008)--digest version. Circ J (2010) 1.51
Rotational ablation and stent placement for severe calcific coronary artery stenosis after Kawasaki disease. Catheter Cardiovasc Interv (2002) 1.45
Acute coronary syndrome in adult patients with coronary artery lesions caused by Kawasaki disease: review of case reports. Cardiol Young (2010) 1.29
Long-term outcome of Kawasaki disease. Circulation (2008) 1.08
Spatial and temporal clustering of Kawasaki syndrome cases. Pediatr Infect Dis J (2008) 1.05
Interventions in Kawasaki disease. Pediatr Cardiol (2005) 0.95
Acute coronary artery dilation due to Kawasaki disease and subsequent late calcification as detected by electron beam computed tomography. Pediatr Cardiol (2007) 0.92
Remodeling of coronary artery lesions due to Kawasaki disease: comparison of arteriographic and immunohistochemical findings. Jpn Heart J (2000) 0.92
Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. Circ J (2009) 0.89
Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease. J Rheumatol (2005) 0.84
Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 4.14
ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet (2007) 2.77
A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet (2009) 2.45
Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr (2008) 2.44
Can we still rely on the ECG for detecting past myocardial injury? JACC Cardiovasc Imaging (2013) 2.02
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet (2011) 1.97
When children with Kawasaki disease grow up: Myocardial and vascular complications in adulthood. J Am Coll Cardiol (2009) 1.88
The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A (2013) 1.78
Smallpox vaccination and myopericarditis: a clinical review. J Am Coll Cardiol (2004) 1.65
A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet (2012) 1.58
Point-of-care differentiation of Kawasaki disease from other febrile illnesses. J Pediatr (2012) 1.55
Low plasma D-dimer concentration predicts the absence of traumatic brain injury in children. J Trauma (2010) 1.50
Aspirin for primary prevention of coronary heart disease: using the Framingham Risk Score to improve utilization in a primary care clinic. South Med J (2008) 1.48
Impressions of Kawasaki syndrome in India. Indian Pediatr (2006) 1.47
Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet (2010) 1.45
Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol (2007) 1.39
Association of Kawasaki disease with tropospheric wind patterns. Sci Rep (2011) 1.38
Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. Eur J Biochem (2002) 1.37
Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. J Pediatr (2010) 1.34
Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics (2010) 1.33
Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol (2005) 1.33
Discovery and characterization of two isoforms of moronecidin, a novel antimicrobial peptide from hybrid striped bass. J Biol Chem (2001) 1.26
Evaluating fluctuations in human atrial fibrillatory cycle length using monophasic action potentials. Pacing Clin Electrophysiol (2006) 1.22
A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses. BMC Med (2011) 1.21
Kawasaki disease: late cardiovascular sequelae. Curr Opin Cardiol (2012) 1.21
Recognition of a Kawasaki disease shock syndrome. Pediatrics (2009) 1.17
Failure to diagnose Kawasaki disease at the extremes of the pediatric age range. Pediatr Infect Dis J (2004) 1.17
Separating atrial flutter from atrial fibrillation with apparent electrocardiographic organization using dominant and narrow F-wave spectra. J Am Coll Cardiol (2005) 1.14
Memory T-cells and characterization of peripheral T-cell clones in acute Kawasaki disease. Autoimmunity (2010) 1.12
Differential expression of miR-145 in children with Kawasaki disease. PLoS One (2013) 1.12
Upregulation of vascular calcium channels in neonatal piglets with hypoxia-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2008) 1.11
Patient-specific multiscale modeling of blood flow for coronary artery bypass graft surgery. Ann Biomed Eng (2012) 1.08
Delayed diagnosis by physicians contributes to the development of coronary artery aneurysms in children with Kawasaki syndrome. Pediatr Infect Dis J (2007) 1.07
Spatial and temporal clustering of Kawasaki syndrome cases. Pediatr Infect Dis J (2008) 1.05
Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol (2013) 1.05
Evolution of laboratory values in patients with Kawasaki disease. Pediatr Infect Dis J (2011) 1.03
Reply to: "Experimental aspects of copy number variant assays at CCL3L1". Nat Med (2009) 1.03
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation (2017) 1.02
Replication and meta-analysis of GWAS identified susceptibility loci in Kawasaki disease confirm the importance of B lymphoid tyrosine kinase (BLK) in disease susceptibility. PLoS One (2013) 0.99
Gene transcript abundance profiles distinguish Kawasaki disease from adenovirus infection. J Infect Dis (2009) 0.99
Lymph-node-first presentation of Kawasaki disease compared with bacterial cervical adenitis and typical Kawasaki disease. J Pediatr (2013) 0.99
Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr (2012) 0.98
Incidence of Kawasaki disease in northern European countries. Pediatr Int (2012) 0.98
Cardiovascular biomarkers in acute Kawasaki disease. Int J Cardiol (2011) 0.98
Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki disease. J Infect Dis (2005) 0.97
Kawasaki disease and human coronavirus. J Infect Dis (2005) 0.97
Is Kawasaki disease incidence rising in Chandigarh, North India? Arch Dis Child (2010) 0.97
Bright light therapy protects women from circadian rhythm desynchronization during chemotherapy for breast cancer. Behav Sleep Med (2012) 0.97
Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease. J Hum Genet (2010) 0.96
Rethinking the boundaries of Kawasaki disease: toward a revised case definition. Perspect Biol Med (2003) 0.96
Organization and expression analysis of the zebrafish hepcidin gene, an antimicrobial peptide gene conserved among vertebrates. Dev Comp Immunol (2004) 0.95
Adenovirus, adeno-associated virus and Kawasaki disease. Pediatr Infect Dis J (2005) 0.95
Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G. PLoS One (2013) 0.94
Coronary artery dilation in acute Kawasaki disease and acute illnesses associated with Fever. Pediatr Infect Dis J (2012) 0.93
Insulin-stimulated NADH/NAD+ redox state increases NAD(P)H oxidase activity in cultured rat vascular smooth muscle cells. Am J Hypertens (2006) 0.93
Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis. Clin Proteomics (2010) 0.93
Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance. Hum Immunol (2010) 0.93
The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol (2012) 0.92
Familial occurrence of Kawasaki syndrome in North America. Arch Pediatr Adolesc Med (2005) 0.92
Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease. J Med Genet (2011) 0.92
Specificity of regulatory T cells that modulate vascular inflammation. Autoimmunity (2014) 0.92
Noninvasive assessment of pulmonary vascular resistance using Doppler tissue imaging of the tricuspid annulus. J Am Soc Echocardiogr (2007) 0.91
Light treatment prevents fatigue in women undergoing chemotherapy for breast cancer. Support Care Cancer (2011) 0.91
Kawasaki disease in India: increasing awareness or increased incidence? Perspect Biol Med (2009) 0.91
Image-based modeling of hemodynamics in coronary artery aneurysms caused by Kawasaki disease. Biomech Model Mechanobiol (2011) 0.90
Direct imaging and quantification of carotid plaque calcification. Magn Reson Med (2010) 0.90
ACC/AHA/SCAI 2014 health policy statement on structured reporting for the cardiac catheterization laboratory: a report of the American College of Cardiology Clinical Quality Committee. J Am Coll Cardiol (2014) 0.89
Insulin-stimulated cyclic guanosine monophosphate inhibits vascular smooth muscle cell migration by inhibiting Ca/calmodulin-dependent protein kinase II. Circulation (2003) 0.89
Quantitation of adenovirus genome during acute infection in normal children. Pediatr Infect Dis J (2005) 0.89
Kawasaki disease in monozygotic twins. Pediatr Infect Dis J (2011) 0.88
The two emergencies of Kawasaki syndrome and the implications for the developing world. Pediatr Infect Dis J (2008) 0.87
Insulin-stimulated NAD(P)H oxidase activity increases migration of cultured vascular smooth muscle cells. Am J Hypertens (2005) 0.87
Recurrent Kawasaki disease-like syndrome in a patient with acquired immunodeficiency syndrome. Clin Infect Dis (2002) 0.87
Calcium scoring in patients with a history of Kawasaki disease. JACC Cardiovasc Imaging (2012) 0.86
Recurrent fever syndromes in patients after recovery from Kawasaki syndrome. Pediatrics (2011) 0.85
Endoplasmic reticulum stress drives a regulatory phenotype in human T-cell clones. Cell Immunol (2010) 0.85
Cross-reactive neutralizing antibody against pandemic 2009 H1N1 influenza a virus in intravenous immunoglobulin preparations. Pediatr Infect Dis J (2011) 0.85
Genetics insights into the pathogenesis of Kawasaki disease. Circ Cardiovasc Genet (2012) 0.84
Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children. PLoS One (2010) 0.84
Insulin-inhibited and stimulated cultured vascular smooth muscle cell migration are related to divergent effects on protein phosphatase-2A and autonomous calcium/calmodulin-dependent protein kinase II. Atherosclerosis (2007) 0.82
Utility of cardiac magnetic resonance imaging in evaluating left ventricular pseudoaneurysm. Congest Heart Fail (2008) 0.82
Bronchial circulation angiogenesis in the rat quantified with SPECT and micro-CT. Eur J Nucl Med Mol Imaging (2008) 0.81
A simple method for assessment of human anti-Neu5Gc antibodies applied to Kawasaki disease. PLoS One (2013) 0.81
Hypercapnic acidosis and compensated hypercapnia in control and pulmonary hypertensive piglets. Pediatr Pulmonol (2003) 0.81
Disruption of vascular homeostasis in patients with Kawasaki disease: involvement of vascular endothelial growth factor and angiopoietins. Arthritis Rheum (2012) 0.81
Insulin-stimulated hydrogen peroxide increases guanylate cyclase activity in vascular smooth muscle. Hypertension (2003) 0.80
Pyuria associated with acute Kawasaki disease and fever from other causes. Pediatr Infect Dis J (2009) 0.80
Characterization of a white bass (Morone chrysops) embryonic cell line with epithelial features. In Vitro Cell Dev Biol Anim (2003) 0.80
Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets. Pulm Circ (2012) 0.80